A detailed history of Raymond James & Associates transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Raymond James & Associates holds 57,383 shares of IDXX stock, worth $24.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
57,383
Previous 79,406 27.73%
Holding current value
$24.1 Million
Previous $38.7 Million 25.09%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$455.08 - $517.19 $10 Million - $11.4 Million
-22,023 Reduced 27.73%
57,383 $29 Million
Q2 2024

Jul 19, 2024

BUY
$468.04 - $548.53 $2.37 Million - $2.78 Million
5,072 Added 6.82%
79,406 $38.7 Million
Q1 2024

Apr 22, 2024

BUY
$515.08 - $576.87 $720,596 - $807,041
1,399 Added 1.92%
74,334 $40.1 Million
Q4 2023

Jan 16, 2024

SELL
$391.37 - $557.56 $9.81 Million - $14 Million
-25,059 Reduced 25.57%
72,935 $40.5 Million
Q3 2023

Oct 24, 2023

BUY
$432.42 - $556.67 $10.4 Million - $13.4 Million
24,147 Added 32.7%
97,994 $42.8 Million
Q2 2023

Jul 25, 2023

SELL
$450.7 - $503.61 $1.55 Million - $1.73 Million
-3,429 Reduced 4.44%
73,847 $37.1 Million
Q1 2023

Apr 14, 2023

BUY
$406.01 - $514.59 $4.27 Million - $5.42 Million
10,525 Added 15.77%
77,276 $38.6 Million
Q4 2022

Feb 08, 2023

SELL
$324.64 - $441.27 $437,290 - $594,390
-1,347 Reduced 1.98%
66,751 $27.2 Million
Q3 2022

Oct 25, 2022

SELL
$325.8 - $407.78 $1.56 Million - $1.95 Million
-4,778 Reduced 6.56%
68,098 $22.2 Million
Q2 2022

Aug 12, 2022

SELL
$327.37 - $553.44 $2.5 Million - $4.22 Million
-7,627 Reduced 9.47%
72,876 $25.6 Million
Q1 2022

May 11, 2022

BUY
$466.52 - $631.01 $1.56 Million - $2.11 Million
3,345 Added 4.34%
80,503 $44 Million
Q4 2021

Feb 08, 2022

BUY
$586.54 - $666.48 $1.38 Million - $1.57 Million
2,354 Added 3.15%
77,158 $50.8 Million
Q3 2021

Nov 02, 2021

BUY
$621.9 - $705.76 $1.15 Million - $1.3 Million
1,847 Added 2.53%
74,804 $46.5 Million
Q2 2021

Aug 11, 2021

BUY
$486.36 - $637.08 $2.69 Million - $3.52 Million
5,525 Added 8.19%
72,957 $46.1 Million
Q1 2021

May 14, 2021

BUY
$465.18 - $551.79 $2.49 Million - $2.95 Million
5,351 Added 8.62%
67,432 $33 Million
Q4 2020

Feb 12, 2021

BUY
$383.85 - $499.87 $5.08 Million - $6.61 Million
13,229 Added 27.08%
62,081 $31 Million
Q3 2020

Nov 04, 2020

BUY
$334.54 - $406.31 $3.4 Million - $4.13 Million
10,158 Added 26.25%
48,852 $19.2 Million
Q2 2020

Jul 28, 2020

BUY
$230.66 - $330.16 $367,672 - $526,275
1,594 Added 4.3%
38,694 $12.8 Million
Q1 2020

Apr 21, 2020

SELL
$182.94 - $290.97 $192,087 - $305,518
-1,050 Reduced 2.75%
37,100 $8.99 Million
Q4 2019

Feb 12, 2020

SELL
$248.66 - $285.01 $1.03 Million - $1.18 Million
-4,154 Reduced 9.82%
38,150 $9.96 Million
Q3 2019

Nov 07, 2019

SELL
$260.07 - $289.93 $105,848 - $118,001
-407 Reduced 0.95%
42,304 $11.5 Million
Q2 2019

Aug 06, 2019

BUY
$215.53 - $275.33 $1.87 Million - $2.39 Million
8,692 Added 25.55%
42,711 $11.8 Million
Q1 2019

May 06, 2019

SELL
$178.02 - $225.69 $1.24 Million - $1.57 Million
-6,970 Reduced 17.0%
34,019 $7.61 Million
Q4 2018

Feb 11, 2019

BUY
$176.18 - $248.92 $1.57 Million - $2.22 Million
8,911 Added 27.78%
40,989 $7.63 Million
Q3 2018

Nov 14, 2018

BUY
$218.82 - $254.46 $1.6 Million - $1.86 Million
7,326 Added 29.6%
32,078 $8.01 Million
Q2 2018

Aug 14, 2018

SELL
$185.56 - $227.9 $314,153 - $385,834
-1,693 Reduced 6.4%
24,752 $5.39 Million
Q1 2018

May 14, 2018

BUY
$157.81 - $204.73 $138,557 - $179,752
878 Added 3.43%
26,445 $5.06 Million
Q4 2017

Feb 14, 2018

SELL
$147.68 - $168.37 $2.22 Million - $2.53 Million
-15,014 Reduced 37.0%
25,567 $4 Million
Q3 2017

Nov 13, 2017

SELL
$150.32 - $166.46 $746,038 - $826,140
-4,963 Reduced 10.9%
40,581 $6.31 Million
Q2 2017

Aug 14, 2017

BUY
N/A
45,544
45,544 $7.35 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.9B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.